These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 380326)

  • 41. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization.
    Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ
    Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466
    [No Abstract]   [Full Text] [Related]  

  • 42. Transfusion-associated immune modulation: a reason to TRIM platelet transfusions?
    Geiger TL
    Transfusion; 2008 Sep; 48(9):1772-3. PubMed ID: 18811896
    [No Abstract]   [Full Text] [Related]  

  • 43. HLA-reduced platelets to overcome platelet refractoriness: can lemons help?
    Sirchia G
    Transfusion; 1996 May; 36(5):388-91. PubMed ID: 8693499
    [No Abstract]   [Full Text] [Related]  

  • 44. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
    Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
    Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelets as immunogens.
    Waters AH
    Vox Sang; 1994; 67 Suppl 3():125-7. PubMed ID: 7975474
    [No Abstract]   [Full Text] [Related]  

  • 46. Predictive value of cross-matching for transfusion of platelet concentrates to alloimmunized recipients.
    Filip DJ; Duquesnoy RJ; Aster RH
    Am J Hematol; 1976; 1(4):471-9. PubMed ID: 1008059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The human histocompatibility complex: a review for the hematologist.
    Miller WV
    Prog Hematol; 1977; 10():173-91. PubMed ID: 337359
    [No Abstract]   [Full Text] [Related]  

  • 48. HLA--C antigens on platelets.
    Mueller-Eckhardt G; Hauck M; Kayser W; Mueller-Eckhardt C
    Tissue Antigens; 1980 Jul; 16(1):91-4. PubMed ID: 6970427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R
    Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe anaphylactic transfusion reaction associated with HLA-incompatible platelets.
    Take H; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J; Miyawaki S; Hirabayashi H
    Br J Haematol; 1993 Apr; 83(4):673-4. PubMed ID: 8518185
    [No Abstract]   [Full Text] [Related]  

  • 51. HLA-matched platelets from unrelated donors in the supportive therapy of patients undergoing intensive haematologic treatment.
    Reali G; Avanzi G; Bacigalupo A; Barbanti M; Ghinatti C; Queirolo MA; Van Lint MT; Marmont A
    Haematologica; 1978 Oct; 63(5):575-85. PubMed ID: 107077
    [No Abstract]   [Full Text] [Related]  

  • 52. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Thrombocyte replacement].
    Fröhlich C
    Hippokrates; 1978 Feb; 49(1):95-7. PubMed ID: 632119
    [No Abstract]   [Full Text] [Related]  

  • 54. [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation].
    Delbos F; Cesbron A
    Transfus Clin Biol; 2017 Sep; 24(3):131-137. PubMed ID: 28757117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human histocompatibility antigens (HLA).
    Kumar R; Mittal KK
    Indian Pediatr; 1983 Oct; 20(10):763-70. PubMed ID: 6373600
    [No Abstract]   [Full Text] [Related]  

  • 56. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
    Wu KK; Hoak JC; Koepke JA; Thompson JS
    Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transfusion of platelets and plasma products.
    Menitove JE; Aster RH
    Clin Haematol; 1983 Feb; 12(1):239-66. PubMed ID: 6340882
    [No Abstract]   [Full Text] [Related]  

  • 58. Refractoriness to platelet transfusions.
    Brubaker DB
    Am J Clin Pathol; 1989 Apr; 91(4):500-1. PubMed ID: 2929507
    [No Abstract]   [Full Text] [Related]  

  • 59. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion.
    Ikeda H; Mitani T; Ohnuma M; Haga H; Ohtzuka S; Kato T; Nakase T; Sekiguchi S
    Vox Sang; 1989; 57(3):213-7. PubMed ID: 2617957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.